UCFA
ARCT icon

United Capital Financial Advisors’s Arcturus Therapeutics ARCT Stock Holding History

United Capital Financial Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,948
Closed -$370K – 1041
2022
Q3 		$370K Buy
24,948
+11
+0% +$185 ﹤0.01% 846
2022
Q2 		$393K Buy
24,937
+1
+0% +$20 ﹤0.01% 858
2022
Q1 		$672K Buy
24,936
+11
+0% +$281 ﹤0.01% 768
2021
Q4 		$922K Buy
24,925
+5
+0% +$204 ﹤0.01% 694
2021
Q3 		$1.19M Hold
24,920
– – 0.01% 629
2021
Q2 		$843K Sell
24,920
-5
-0% -$169 ﹤0.01% 735
2021
Q1 		$1.03M Sell
24,925
-1,341
-5% -$79.9K 0.01% 660
2020
Q4 		$1.14M Sell
26,266
-2,130
-8% -$144K 0.01% 645
2020
Q3 		$1.22M Sell
28,396
-1,204
-4% -$59.8K 0.01% 603
2020
Q2 		$1.38M Hold
29,600
– – 0.01% 585
2020
Q1 		$402K Hold
29,600
– – ﹤0.01% 890
2019
Q4 		$322K Hold
29,600
– – ﹤0.01% 1115
2019
Q3 		$304K Buy
29,600
+2,300
+8% +$24.9K ﹤0.01% 1073
2019
Q2 		$258K Hold
27,300
– – ﹤0.01% 1272
2019
Q1 		$186K Hold
27,300
– – ﹤0.01% 1283
2018
Q4 		$124K Hold
27,300
– – ﹤0.01% 1234
2018
Q3 		$241K Hold
27,300
– – ﹤0.01% 1194
2018
Q2 		$232K Buy
27,300
+12,800
+88% +$82.9K ﹤0.01% 1183
2018
Q1 		$80K Buy
+14,500
New +$100K ﹤0.01% 1278

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

United Capital Financial Advisors's ARCT Position: Q4 2022 in Review

United Capital Financial Advisors sold out of Arcturus Therapeutics (ARCT) in Q4 2022, closing a stake of 24,948 shares — an estimated $370K sold.

United Capital Financial Advisors first reported a position in ARCT in Q1 2018 and held it in 19 quarters. The position peaked at $1.38M in Q2 2020. 113 funds tracked by Wall St. Rank hold ARCT as of Q4 2022.

  • United Capital Financial Advisors reported no remaining Arcturus Therapeutics position as of Q4 2022 after selling out during the quarter.
  • United Capital Financial Advisors sold 24,948 Arcturus Therapeutics shares in Q4 2022, an estimated $370K.
  • United Capital Financial Advisors first reported a position in Arcturus Therapeutics in Q1 2018 and held it in 19 quarters.
  • United Capital Financial Advisors's Arcturus Therapeutics position peaked at $1.38M in Q2 2020.
  • 113 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2022.

Based on United Capital Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.